Diabetic Footwear Market (By Product: Slippers, Sandals, Shoes; By Distribution Channel: Offline, Online) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033
The global diabetic footwear market size was estimated at USD 8.36 billion in 2023 and is anticipated to reach USD 17.45 billion by 2033, growing at a CAGR of 7.64% from 2024 to 2033.
Access our Healthcare Data Intelligence Tool with 10000+ Database, Visit: Towards Healthcare
The U.S. diabetic footwear market size was estimated at USD 1.74 billion in 2023 and is predicted to be worth around USD 3.65 billion by 2033, at a CAGR of 7.68% from 2024 to 2033.
North America, in 2023, held the largest share of the diabetic footwear market. The growth of the North American region is attributed to the presence of prominent market players, the geriatric population, rising awareness regarding diabetic footwear, supportive government initiatives, rising disposable income, increasing incidence of diabetes, and increasing concerns regarding adverse effects associated with diabetic disorders. Thus, this is expected to propel market growth in the region during the forecast period.
Among all countries, the United States is the major contributor to the diabetic footwear market. The country’s growth is majorly driven by the increasing availability of advanced diabetic footwear and constant innovations in the product by the market players. Additionally, the country has a large population suffering from diabetes which increases the awareness among diabetic patients regarding the health benefits of diabetic footwear. Patients with diabetes commonly suffer from foot ulcers, circulation, and others which boost the demand for diabetic footwear to avoid such foot problems.
Asia Pacific is expected to witness the fastest growth during the forecast period in the diabetic footwear market. The growth of the region is attributed to the increasing aging population, increasing incidence of diabetes, increasing disposable income, increasing demand for advanced and feet comfort footwear, and growing awareness about diabetes footwear along with its several benefits. Rising disposable income levels and increasing healthcare spending in countries like China, India, and South Korea have made diabetic footwear more affordable and accessible to a larger segment of the population. As consumers become more willing to invest in preventive healthcare measures and products that improve their quality of life, the diabetic footwear market is poised for further growth in the Asia-Pacific region.
The Asia Pacific diabetic footwear market size was calculated at USD 2.01 billion in 2023 and is estimated to cross around USD 4.28 billion by 2033 with a notable CAGR of 7.85% from 2024 to 2033.
Year | Market Size (USD Billion) |
2023 | 2.01 |
2024 | 2.16 |
2025 | 2.32 |
2026 | 2.50 |
2027 | 2.69 |
2028 | 2.90 |
2029 | 3.12 |
2030 | 3.36 |
2031 | 3.61 |
2032 | 3.89 |
2033 | 4.28 |
People who suffer from diabetes may face problems with blood circulation, nerves, deformities, and immunity. Diabetic footwear is specially designed footwear that safeguards the feet of diabetic patients. The regular use of diabetic footwear may assist in healing several diabetic conditions including inadequate blood circulation in the legs and is intended to minimize the risk of skin breakdown caused by foot deformities. Diabetic footwear is often used by people suffering from foot deformities caused by diabetes. Diabetic footwear has various features including stretchable uppers, non-binding uppers, orthotic support, extra depth design for a pressure-free fit, functional soles, and others.
Diabetic footwear usually has a large toe box for ample room and comfort which are made of soft materials to reduce irritation and offer good cushioning. Diabetic footwear is exceptionally designed to protect while reducing pressure points on the feet and alleviating the risk of amputations. Companies around the world are leveraging cutting-edge technologies to manufacture customized products with enhanced comfort and safety.
Report Coverage | Details |
Growth Rate from 2024 to 2033 | CAGR of 7.64% |
Global Market Size in 2023 | USD 8.36 Billion |
Global Market Size in 2024 | USD 8.99 Billion |
Global Market Size by 2033 | USD 17.45 Billion |
Largest Market | North America |
Base Year | 2023 |
Forecast Period | 2024 to 2033 |
Segments Covered | By Product, and By Distribution Channel |
Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Driver: Increasing prevalence of diabetes
The rising prevalence of diabetes across the globe is anticipated to fuel the growth of the global diabetic footwear market during the forecast period. Diabetes is becoming a very common and lifelong disease. Foot care plays an important role for diabetics. The market has witnessed an increasing usage of diabetic footwear to relieve pain and to provide relief from flat foot pain. The diabetes population often prefers diabetic footwear to prevent foot injuries caused by foot ulcers, infections, poor, blood circulation, and amputation. Diabetic footwear is highly recommended to patients by medical professionals with health conditions including foot ulcers and chronic inflammation or infections brought on by diabetes. Due to the major market participants' aggressive investment, diabetic footwear has been developed to improve blood circulation, keep feet dry, and lower the risk of foot injuries. Consequently, the number of people with diabetes and their healthcare spending are rising dramatically, which is predicted to fuel the market for diabetic footwear.
Restraint: High costs
The high cost associated with diabetic footwear is anticipated to hamper the growth of the diabetic footwear market. Diabetic footwear is expensive and high cost is required for the purchase of this footwear. Along with this, the medically proven footwear solutions require heavy investments for manufacturers. In addition, less awareness of diabetic footwear among the diabetic population as well as regarding its benefits, particularly in underdeveloped countries, is restricting the expansion of the market.
Opportunity: Rising requirement for the elderly population
The increasing demand for diabetic footwear from aging population is projected to offer a lucrative opportunity for the growth of the global diabetic footwear market during the forecast period. The growing geriatric population is highly susceptible to diabetes which leads to the increasing demand for tooth diabetic footwear. Diabetic footwear comes with excellent elements such as raw material and comfort and these footwears are becoming increasingly popular among the geriatric population with diabetes. Thus, diabetic footwear assists in increasing blood circulation and nerve sensation and reduces pressure in the areas of the foot most susceptible to pain.
The shoes segment accounted for the dominating share in 2023 in the diabetic footwear market due to the rapid pace of urbanization and the rising office-going population around the world. Diabetes footwear is comfortable to wear for long hours and safeguards feet from injuries as well as alleviating the occurrence of fungal infections. The rising use of diabetic footwear is projected to accelerate the segment’s growth. The rising importance of exercise, walking and running among diabetic patients is observed to create a potential growth factor for the shoes segment to grow in the upcoming period.
On the other hand, the slippers segment is expected to witness a significant share during the forecast period in the diabetic footwear market owing to the increasing use of diabetic slippers in daily life to prevent foot ulcers and enhance blood circulation. The convenience offered by slippers as a footwear solution is observed to promote the segment’s expansion. Slippers for diabetic patients is observed to offer precise acupressure for the feet, thereby the popularity of slippers as diabetic footwear is significantly growing.
The offline segment held the largest share of the diabetic footwear market in 2023. Offline channels such as specialty stores, pharma outlets, and others are anticipated to remain the highly customer-preferred channels for purchasing diabetic footwear. The rapid urbanization coupled with rising disposable income in developing nations is projected to propel the growth of the segment. For instance, FitStarter is a personalized footwear recommendation tool that Aetrex, Inc. unveiled in November 2023 with the goal of assisting stores in better fitting customers' shoes, decreasing returns, and raising customer happiness. Developed in collaboration with Heeluxe, the leading provider of shoe fit testing services. FitStarter is a simple add-on for retailers using their current Albert 3D foot scanner software (Albert 2 Pro or Albert 3DFit).
On the other hand, the online segment is expected to grow at a robust growth rate during the forecast period in the diabetic footwear market. The growth of the segment is majorly driven by the rising popularity of e-commerce portals and their attractive discounts offered to the customers. E-commerce service providers such as Flipkart, Myntra, and Amazon offer various value-added services such as Cash-on-Delivery, coupon benefits, free home delivery, and others. Thereby boosting the segment’s growth in the market.
Segments Covered in the Report:
By Product
By Distribution Channel
By Geography
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Diabetic Footwear Market
5.1. COVID-19 Landscape: Diabetic Footwear Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Diabetic Footwear Market, By Product
8.1. Diabetic Footwear Market Revenue and Volume, by Product, 2024-2033
8.1.1. Slippers
8.1.1.1. Market Revenue and Volume Forecast (2021-2033)
8.1.2. Sandals
8.1.2.1. Market Revenue and Volume Forecast (2021-2033)
8.1.3. Shoes
8.1.3.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 9. Global Diabetic Footwear Market, By Distribution Channel
9.1. Diabetic Footwear Market Revenue and Volume, by Distribution Channel, 2024-2033
9.1.1. Offline
9.1.1.1. Market Revenue and Volume Forecast (2021-2033)
9.1.2. Online
9.1.2.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 10. Global Diabetic Footwear Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Volume Forecast, by Product (2021-2033)
10.1.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)
10.1.3. U.S.
10.1.3.1. Market Revenue and Volume Forecast, by Product (2021-2033)
10.1.3.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Volume Forecast, by Product (2021-2033)
10.1.4.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)
10.2. Europe
10.2.1. Market Revenue and Volume Forecast, by Product (2021-2033)
10.2.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)
10.2.3. UK
10.2.3.1. Market Revenue and Volume Forecast, by Product (2021-2033)
10.2.3.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)
10.2.4. Germany
10.2.4.1. Market Revenue and Volume Forecast, by Product (2021-2033)
10.2.4.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)
10.2.5. France
10.2.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)
10.2.5.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)
10.2.6.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)
10.3. APAC
10.3.1. Market Revenue and Volume Forecast, by Product (2021-2033)
10.3.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)
10.3.3. India
10.3.3.1. Market Revenue and Volume Forecast, by Product (2021-2033)
10.3.3.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)
10.3.4. China
10.3.4.1. Market Revenue and Volume Forecast, by Product (2021-2033)
10.3.4.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)
10.3.5. Japan
10.3.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)
10.3.5.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)
10.3.6.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)
10.4. MEA
10.4.1. Market Revenue and Volume Forecast, by Product (2021-2033)
10.4.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)
10.4.3. GCC
10.4.3.1. Market Revenue and Volume Forecast, by Product (2021-2033)
10.4.3.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)
10.4.4. North Africa
10.4.4.1. Market Revenue and Volume Forecast, by Product (2021-2033)
10.4.4.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)
10.4.5. South Africa
10.4.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)
10.4.5.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)
10.4.6.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)
10.5. Latin America
10.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)
10.5.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)
10.5.3. Brazil
10.5.3.1. Market Revenue and Volume Forecast, by Product (2021-2033)
10.5.3.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Volume Forecast, by Product (2021-2033)
10.5.4.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)
Chapter 11. Company Profiles
11.1. Aetrex Worldwide Inc.
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Orthofeet Inc.
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. DJO Global Inc.
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Dr. Zen Products Inc.
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Drew Shoe Corporation
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Podartis srl Unipersonale
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Propét USA Inc.
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Hanger Inc.
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Healer Health LLC
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Pilgrim Shoes
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client